GlassScriptPhysician profile
Nathan R Brought
NPI 1285834754
$7,439.40
in general payments reported to CMS, 2019-2025
11 companies · $1,789 in 2025
The $1,789 reported for 2025 was more than what 83% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,442 · 2020: $349 · 2021: $190 · 2022: $213 · 2023: $294 · 2024: $2,163 · 2025: $1,789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,343 · Travel and Lodging: $1,816 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,342.86 |
| Travel and Lodging | $1,816.10 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $2,127.34 | 2019 | |
| Convatec INC. | $1,659.35 | 2024 | |
| Motiva USA, LLC | $1,563.69 | 2024-2025 | |
| Mentor Worldwide LLC | $1,124.88 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 4 Breast Tissue Expander |
| Organogenesis INC. | $359.39 | 2021-2024 | Puraply Am |
| Medline Industries LP | $206.75 | 2019-2020 | |
| Tela Bio, INC. | $155.84 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Integra Lifesciences Corporation | $108.30 | 2023 | Durasorb Monofilament Mesh |
| Smith+Nephew, INC. | $64.28 | 2023-2025 | Pico, Pico 14 |
| Innovation Technologies INC | $46.57 | 2025 | Irrisept |
| Musculoskeletal Transplant Foundation INC. | $23.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Brought listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.